Skip to main content
Skip to content
Case File
efta-01522090DOJ Data Set 10Other

EFTA01522090

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522090
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL- OAP FDG ACCT. For the Period 10/1/II to loaini Equity Summary Asset Categories US Large Cap Equity Beginning Ending Change Current Market Value Market Value In Value Allocation 145,237 97 156 591 73 Market Value/Cost Current Penod Value Market Value 156,591.73 Tax Cost 147,157.52 Unrealized Gain/Loss 9,434.21 Estimated Annual Income 5,389.64 Accrued Dividends 527.15 Yield 3.44% Equity Detail 11,353.76 98% Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc Yield Original Cost Accrued Div. US Large Cap Equity ABBOTT LABORATORIES 53.87 148.000 7,972.78 7,308.74 664.02 284.16 3 56% 002824-10-0 ABT 71.04 AIR PRODUCTS & CHEMICALS INC 86.14 86.030 7,408.04 7,148.42 259.62 199.52 2.69% 009158-10.6 APD 49.88 AUTOMATIC DATA PROCESSING INC 52.33 150.000 7,849.50 7.264.05 585.45 216.00 2.75% 053015-10-3 ADP JP Morgan Page 4 of 10 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049569 SDNY_GM_00318767 EFTA01522090

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.